Showing results (1801-1810 of 1,837) with videos related to
Sort By:
Pageof 184
Cancer Immunology, Immunotherapy : CII|August 31, 2022
Divergent clinical outcomes in a phase 2B trial of the TLPLDC vaccine in preventing melanoma recurrence and the impact of dendritic cell collection methodology: a randomized clinical trialAlexandra M Adams, Elizabeth L Carpenter, Guy T Clifton, et al.Journal of Medicinal Chemistry|October 2, 2009
Modeling, synthesis and biological evaluation of potential retinoid X receptor (RXR) selective agonists: novel analogues of 4-[1-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)ethynyl]benzoic acid (bexarotene)Carl E Wagner, Peter W Jurutka, Pamela A Marshall, et al.International Journal of Molecular Sciences|November 27, 2021
Modeling, Synthesis, and Biological Evaluation of Potential Retinoid-X-Receptor (RXR) Selective Agonists: Analogs of 4-[1-(3,5,5,8,8-Pentamethyl-5,6,7,8-tetrahyro-2-naphthyl)ethynyl]benzoic Acid (Bexarotene) and 6-(Ethyl(4-isobutoxy-3-isopropylphenyl)amino)nicotinic Acid (NEt-4IB)Peter W Jurutka, Orsola di Martino, Sabeeha Reshi, et al.Chemmedchem|August 29, 2012
Modeling, synthesis and biological evaluation of potential retinoid X receptor-selective agonists: novel halogenated analogues of 4-[1-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)ethynyl]benzoic acid (bexarotene)Julie K Furmick, Ichiro Kaneko, Angela N Walsh, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|May 5, 2011
Stem cell gene therapy for fanconi anemia: report from the 1st international Fanconi anemia gene therapy working group meetingJakub Tolar, Jennifer E Adair, Michael Antoniou, et al.Proceedings of the National Academy of Sciences of the United States of America|October 19, 2001
SCH-C (SCH 351125), an orally bioavailable, small molecule antagonist of the chemokine receptor CCR5, is a potent inhibitor of HIV-1 infection in vitro and in vivoJ M Strizki, S Xu, N E Wagner, et al.Bioorganic & Medicinal Chemistry|January 14, 2025
Modeling, synthesis and cell-based evaluation of pyridine-substituted analogs of CD3254 and fluorinated analogs of CBt-PMN as novel therapeuticsPeter W Jurutka, Zainab Khan, Ichiro Kaneko, et al.International Journal of Molecular Sciences|December 23, 2022
An Isochroman Analog of CD3254 and Allyl-, Isochroman-Analogs of NEt-TMN Prove to Be More Potent Retinoid-X-Receptor (RXR) Selective Agonists Than BexarotenePeter W Jurutka, Orsola di Martino, Sabeeha Reshi, et al.NPJ Genomic Medicine|June 30, 2021
Broadening INPP5E phenotypic spectrum: detection of rare variants in syndromic and non-syndromic IRDRiccardo Sangermano, Iris Deitch, Virginie G Peter, et al.Biorxiv : the Preprint Server for Biology|July 9, 2025
Two parallel lineage-committed progenitors contribute to the developing brainCarolyn E Dundes, Rayyan T Jokhai, Hadia Ahsan, et al.Pageof 184